Inhibiting miR-21 in exosomes not only improves the proliferation and cytotoxic activity of CD8+ T cells but also reduces the level of TGF-β1, which prevents immune escape of glioma cells (61). The gene discussed is CD8A; the disease is central nervous system cancer.